Business Standard

Sunday, December 22, 2024 | 09:48 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

STATSGURU: Here's how the world's coronavirus vaccine map looks like

Most vaccines are not yet available in plenty, and are costly, too

AstraZeneca wasn't the obvious choice to partner up with Oxford when scientists there started developing a coronavirus shot. Photographer: Mikael Sjoberg/Bloomberg
Premium

Abhishek Waghmare
The three leading Covid-19 vaccines are making their way towards the first line of beneficiaries. While the Pfizer and Moderna vaccines are being administered in tens of countries, the Oxford-AstraZeneca (Ox-As) jab was recently approved by India. All of them, to varying extent, have proven to be effective enough for usage. But the Ox-As vaccine fares the best in terms of commitment towards a more equitable distribution, chart 1 shows.




Most vaccines are not yet available in plenty, and are costly, too. So much so that rich countries have taken the lead in purchase deals, and reported

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in